Skip to main content
Log in

Is C-11 Methionine PET/CT Able to Localise Sestamibi-Negative Parathyroid Adenomas?

  • Original Scientific Report
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Patients with primary hyperparathyroidism (pHPT) and a negative preoperative Tc-99 sestamibi (MIBI) scintigraphy are considered to have a higher risk of persistent disease. The aim of this study was to assess whether additional imaging with C-11 methionine positron emission tomography/computed tomography (Met-PET/CT) is able to localise sestamibi-negative hyperfunctioning parathyroid glands.

Methods

In 50 patients (38 females, 12 males, age 13–81 years) with pHPT and negative localisation procedures such as ultrasound and sestamibi, a Met-PET/CT was performed before parathyroid surgery. The results of Met-PET/CT were analysed prospectively and compared with intraoperative and histopathological findings. 22% of the patients underwent previous parathyroid and/or thyroid surgery.

Results

Met-PET/CT correctly located a single-gland adenoma in 33 of 45 (73%) patients with pHPT. In 5 patients with multiglandular disease, Met-PET/CT detected at least one hyperfunctional parathyroid gland in 4 patients (80%). In 3 patients with double adenomas, 5 of 6 parathyroids were correctly located. Overall, 40 of 57 (70%) hyperfunctioning glands were identified with Met-PET/CT. Met-PET/CT was false-negative in 12 of 50 (24%) patients and false-positive in only one case (2%). Postoperatively, 48 of 50 patients (96%) were cured.

Conclusions

Additional pre-interventional imaging with Met-PET/CT was able to identify hyperfunctioning parathyroid glands in 74% of patients with pHPT and negative sestamibi scans, thus enabling successful parathyroid surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bergenfelz AO, Hellman P, Harrison B, Sitges-Serra A, Dralle H (2009) Positional statement of the European Society of Endocrine Surgeons (ESES) on modern techniques in pHPT surgery. Langenbecks Arch Surg 394:761–764

    Article  PubMed  Google Scholar 

  2. Elaraj DM, Sippel RS, Lindsay S, Sansano I, Duh Q-Y, Clark OH, Kebebew E (2010) Are additional localization studies and referral indicated for patients with primary hyperparathyroidism who have negative sestamibi scan results? Arch Surg 145:578–581

    Article  PubMed  Google Scholar 

  3. Bergenfelz AOJ, Wallin G, Jansson S, Eriksson H, Martensson H, Christiansen P, Reihner E (2012) Results of surgery for sporadic primary hyperparathyroidism in patients with preoperatively negative sestamibi scintigraphy and ultrasound. Langenbecks Arch Surg 396:83–90

    Article  Google Scholar 

  4. Dy BM, Richards ML, Vazquez BJ, Thompson GB, Farley DR, Grant CS (2012) Primary hyperparathyroidism and negative Tc99 sestamibi imaging: to operate or not? Ann Surg Oncol 19:2272–2278

    Article  PubMed  Google Scholar 

  5. Hellman P, Ahlström H, Bergström M, Sundin A, Langström B, Westerberg G, Juhlin C, Akerström G, Rastad J (1994) Positron emission tomography with 11C-methionine in hyperparathyroidism. Surgery 116:974–981

    CAS  PubMed  Google Scholar 

  6. Sundin A, Johansson C, Hellman P, Bergström M, Ahlström H, Jacobson GB, Langström B, Rastad J (1996) PET and parathyroid L-[carbon-11]methionine accumulation in hyperparathyroidism. J Nucl Med 37:1766–1770

    CAS  PubMed  Google Scholar 

  7. Cook GJR, Wong JCH, Smellie WJB, Young AE, Maisey MN, Fogelman I (1998) [11C] Methionine positron emission tomography for patients with persistent or recurrent hyperparathyroidism after surgery. Eur J Endocrinol 139:195–197

    Article  CAS  PubMed  Google Scholar 

  8. Hessman O, Stalberg P, Sundin A, Garske U, Rudberg C, Eriksson L-G, Akerström G (2008) High success rate of parathyroid reoperation may be achieved with improved localization diagnosis. World J Surg 32:774–781. doi:10.1007/s00268-008-9537-5 

    Article  PubMed  Google Scholar 

  9. Tang B-N-T, Moreno-Reyes R, Blocklet D, Corvilain B, Cappello M, Delpierre I, Devuyst F, Van Simaeys G, Goldman S (2008) Accurate pre-operative localization of pathological parathyroid glands using 11C-methionine PET/CT. Contrast Media Mol Imaging 3:157–163

    Article  CAS  PubMed  Google Scholar 

  10. Weber T, Cammerer G, Schick C, Solbach C, Hillenbrand A, Barth TF, Henne-Bruns D, Blagieva R, Böhm BO, Reske SN, Luster M (2010) C-11 methionine positron emission tomography/computed tomography localizes parathyroid adenomas in primary hyperparathyroidism. Horm Metab Res 42:209–214

    Article  CAS  PubMed  Google Scholar 

  11. Weber T, Maier-Funk C, Ohlhauser D, Hillenbrand A, Cammerer G, Barth TF, Henne-Bruns D, Boehm BO, Reske SN, Luster M (2013) Accurate preoperative localization of parathyroid adenomas with C-11 methionine PET/CT. Ann Surg 257:1124–1128

    Article  PubMed  Google Scholar 

  12. Chun IK, Cheon GJ, Paeng JC, Kang KW, Chung JK, Lee DS (2013) Detection and Characterization of parathyroid adenoma/hyperplasia for preoperative localization: comparison between (11)C—methionine PET/CT and (99 m)Tc-sestamibi scintigraphy. Nucl Med Mol Imaging 47:166–172

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Traub-Weidinger T, Mayerhoefer ME, Koperek O, Mitterhauser M, Duan H, Karanikas G, Niederle B, Hoffmann M (2014) 11C-methionine PET/CT imaging of 99mTc-MIBI-SPECT/CT negative patients with primary hyperparathyroidism and previous neck surgery. JCEM 99:4199–4205

    CAS  PubMed  Google Scholar 

  14. Bergenfelz AO, Jansson SK, Wallin GK, Martenson HG, Rasmussen L, Eriksson HL, Reihnér EI (2009) Impact of modern techniques on short-term outcome after surgery for primary hyperparathyroidism: a multicentre study comprising 2708 patients. Langenbecks Arch Surg 394:851–860

    Article  PubMed  Google Scholar 

  15. Bagul A, Patel HP, Chadwick D, Harrison BJ, Balasubramanian SP (2014) Primary hyperparathyroidism: an analysis of failure of parathyroidectomy. World J Surg 38:534–541. doi:10.1007/s00268-013-2434-6

    Article  CAS  PubMed  Google Scholar 

  16. Schalin-Jäntti C, Ryhänen E, Heiskanen I, Seppänen M, Arola J, Schildt J, Väisänen M, Nelimarkka L, Lisinen I, Aalto V, Nuutila P, Välimäki MJ (2013) Planar scintigraphy with 123I/99mTc-sestamibi, 99mTc-sestamibi SPECT/CT, 11C-methionine PET/CT, or selective venous sampling before reoperation of primary hyperparathyroidism? J Nucl Med 54:739–747

    Article  PubMed  Google Scholar 

  17. Schmidt M, Kahraman D, Neumaier B, Ortmann M, Stippel D (2011) Tc-99 m-MIBI-negative parathyroid adenoma in primary hyperparathyroidism detected by C-11-methionine PET/CT after previous thyroid surgery. Clin Nucl Med 36:1153–1155

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Theresia Weber.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Weber, T., Gottstein, M., Schwenzer, S. et al. Is C-11 Methionine PET/CT Able to Localise Sestamibi-Negative Parathyroid Adenomas?. World J Surg 41, 980–985 (2017). https://doi.org/10.1007/s00268-016-3795-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-016-3795-4

Keywords

Navigation